|
|
|
Volumn 69, Issue 4, 1997, Pages 227-232
|
|
Wilms' tumor: Regent results and future directions;Il tumore di Wilms: Progressi ottenuti e prospettive future
a
|
|
Author keywords
Drug therapy; Late effects; Nephroblastoma; Wilms' tumor
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
DACTINOMYCIN;
DOXORUBICIN;
ETOPOSIDE;
IFOSFAMIDE;
VINCRISTINE;
ANAPLASTIC CARCINOMA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CHILD;
CHROMOSOME 16Q;
CHROMOSOME 1P;
CLEAR CELL CARCINOMA;
CLINICAL PATHWAY;
CLINICAL PROTOCOL;
CONGESTIVE HEART FAILURE;
HETEROZYGOSITY LOSS;
HISTOPATHOLOGY;
HUMAN;
MULTIMODALITY CANCER THERAPY;
NEPHRECTOMY;
NEPHROBLASTOMA;
PROGNOSIS;
REVIEW;
RHABDOID TUMOR;
RISK FACTOR;
SECOND CANCER;
SURGICAL TECHNIQUE;
SURVIVAL RATE;
CHILD;
FORECASTING;
HUMANS;
KIDNEY NEOPLASMS;
PROGNOSIS;
WILMS TUMOR;
|
|
EID: 0030784263
PISSN: 11243562
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (6)
|
|
References (11)
|
